β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
Journal Information
Full Title: J Virol Methods
Abbreviation: J Virol Methods
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
Funding Disclosure
Evidence found in paper:
"Funding sources The project was funded as a special research project of the German Armed Forces Medical Service (02Z9-S-852121) and supported by the COVID-19 Research Network of the State of Lower Saxony (COFONI) (5FT21) through funding from the Ministry of Science and Culture of Lower Saxony in Germany (14-76403-184). DZIF-Fasttrack 1.921 provided means for biosampling."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025